Viewing Study NCT01199068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-05-26 @ 11:07 PM
Study NCT ID: NCT01199068
Status: COMPLETED
Last Update Posted: 2021-05-13
First Post: 2010-08-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
Sponsor: Daiichi Sankyo Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PPAR gamma agonist View
None Tumor View
None Cancer View
None Antineoplastic Agent View
None Respiratory Tract Neoplasms View
None Erlotinib View
None Protein Kinase Inhibitors View
None Neoplasms View